glp-1 for alcohol use disorder Agonists Disorder: UK Evidence and Guidance Can a person with alcohol

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 52 print issues and online access $199.00 per year only $3.83 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

Oral semaglutide (Rybelsus) was the first oral GLP-1 approved by the Food and Drug Administration (FDA)

Drugs that have already demonstrated strong properties in decreasing low-grade systemic inflammation could also act locally at the joint level [17]

Nelis and G

[DOI] [PubMed] [Google Scholar] 58.Alhadeff AL, et al